2Cipollone F, Fazia M,Mincione G, et al. Increased exp ression of transforming growth factor2betal as a stabilizing factor in humanatherosclerotic p laques[J]. Stroke, 2004,35(11) :2253-2257.
1Blackwood W, Hallplke JF, Kocen RS, et al. Atheromatous disease of the carotid arterial system and embolism form the heart in cerebal infraction. Brain, 1996, 92:897.
2Lloyd g Chmbless, Gerardo Heiss, Aaron R Folsom, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclermis Risk in Communnities (ARIC) study. 1987-1993. Am J Epidemiol. 1997. 146:483.
3Sonia S Anand, Salin Yusuf, Vladmir Vuksan, et al. Differences in risk factors, athexosclexosis, and caediovascular disease between ethenic groups in csnada: the Study of Health Assessment and Risk in Ethenic groups (SHARE). The Lancet, 2000, 356:279.
4Mason DP, Kenagy RD, Hasenstab D, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res,1999, 85:1179 - 1185.?A
5Schonbeck U, Mach F, Sukhova GK, et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res, 1997, 81: 448 -454.?A
6Rouis M, Adamy C, Duverger N, et al. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprutein E-deficient mice. Circulation,1999, 100:533 -540.
7Marx N, Sukhova G, Murphy C, et al. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am J Pathol, 1998, 153:17-23.?A
8Geng YJ, Wu Q, Muszynski M, et al. Apoptosis of vascular smooth muscle cells induced by in vitro stinulation with interferon-gamma,tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol, 1996, 16:19-27.?A
9Libby P, Aikawa M. New iosights into plaque stabilisation by lipid lowering. Drugs, 1998, 56(Suppl 1 ): 9 - 13.?A
10Plutzky J. Atherosclerotic plaque rupture: emerging insights and opportunities. Am J Cardiol, 1999, 84(1A): 15J -20J.?A
